RecruitingNCT07481110
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
Sponsor
Société Algérienne de Formation et Recherche en Oncologie
Enrollment
1,000 participants
Start Date
Aug 5, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Eligibility
Min Age: 19 Years
Inclusion Criteria7
- Patients aged 19 years and older
- Histologically confirmed diagnosis of gastric cancer
- Patients followed in the participating oncology departments
- Informed consent obtained
- Histological types other than carcinoma (e.g., GIST, lymphoma, sarcoma, etc.).
- Secondary gastric tumors
- Participation in an interventional study
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07481110
Related Trials
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
NCT051871821 location
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
NCT072774391 location
Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT046742671 location
Study for AZD4360 in Participants With Advanced Solid Tumours
NCT0692192817 locations
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT0570222944 locations